The Latest Breaking News from HUM

Humana has recently outperformed the Healthcare sector, and Wall Street analysts are moderately optimistic about the stock’s prospects.

HCA Healthcare has consistently surpassed the Dow Jones Industrial Average, and analysts are highly optimistic about its prospects.

Elevance Health has outperformed the S&P 500 this year, and analysts remain optimistic about the stock's prospects due to its strong market presence and robust financial performance.

After dipping their toes in the prog pool with 2020's Forgotten Days, Arkansas doom-mongers Pallbearer embrace experimental sounds with new album Mind Burns Alive

CVS Health earnings tumbled more than expected on a surge in Medicare costs due to higher utilization. CVS stock dived, weighing on UNH and HUM.

Here's what could happen next to Humana shares.

The health insurance sector took yet another blow Tuesday as investors see narrowing near-term profits.

Total debit of $5.15 per set of contracts, based on recent trading, for this trade in Humana stock means the break-even cost stands at $375.15.

Humana slashed its Q4 earnings outlook on higher medical costs and warned about weak Medicare Advantage enrollment.

Cigna hiked its CI stock buyback by $10 billion on Sunday. The health insurer reportedly ended talks to buy Humana, CI stock jumped.

The healthcare industry is well-positioned to thrive against most market adversities due to the perennial necessity and surging demand for healthcare services. Given this backdrop, let’s look at buy-worthy health insurance stocks UnitedHealth Group Incorporated (UNH), Humana Inc. (HUM), and Centene Corporation (CNC), which could be solid additions to your…